Camilla Lindan, MD
Diagnostic Radiology · San Francisco, CANPI 1124106752
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 32 payments — averaging $47,510 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.5M
- E.r. Squibb & Sons, L.L.C.$3K
How this compares
$0 in reported general payments places this provider in the 35th percentile of 3,537 diagnostic radiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other diagnostic radiology in San Francisco
- Jerome BarakosSan Francisco$2.5M
- Matthew LungrenSan Francisco$1.6M
- Marc CoelSan Francisco$662K
- Yingbing WangSan Francisco$656K
- Christopher HessSan Francisco$180K
- Javier Villanueva-MeyerSan Francisco$173K
- Benjamin YehSan Francisco$129K
- Michael WangEscondido$14M
- Murray ReicherSan Diego$10.5M
- Charles PeterfyKentfield$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.